Warner-lambert Company

Wolf-Dieter Vigelius

Gerhard Satzinger

Manfred F Herrmann

Spyridon Marinis

Johannes Hartenstein

Edgar Fritschi

New aminosulfonic acids of the general formula I ##STR1## wherein n represents the figures 4, 5, or 6, prepared according to previously known processes and characterized by very good tolerance and valuable cardiovascular properties, serve for the therapy of dysrhythmia and are superior to procaine.

Cycloaliphatic aminosulfonic acid derivatives

The present invention is concerned with new dibenzylglycolic acid derivatives and with the preparation thereof. These derivatives show an extraordinary anti-hypertensive and antisecretory profile.

Dibenzyl glycolic acid derivatives

The present invention relates to novel 1-(aryl)-2-(arylalkyl)-3-(or-4-)-[4'-(substituted alkyl-)-piperazino-1']-butanols-2, and butenes-1 showing antimicrobial action, to their pharmaceutically acceptable salts, and to the process of manufacture thereof.

Growing community of inventors

Denzlingen, Germany

Wolf-Dieter Vigelius